Tower Research Capital LLC (Trc) V Tv Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.65 - $38.8 $2,975 - $177,587	4,577 New	4,577 $4,000
Q2 2022 Aug 15, 2022	SELL	$0.39 - $0.84 $3,034 - $6,536	-7,781 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.51 - $1.0 $3,968 - $7,781	7,781 New	7,781 $6,000
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.69 $38,814 - $69,048	-40,857 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.53 - $2.22 $3,115 - $4,519	2,036 Added 5.24%	40,857 $63,000
Q2 2021 Aug 16, 2021	BUY	$2.27 - $3.44 $63,741 - $96,595	28,080 Added 261.43%	38,821 $89,000
Q1 2021 May 17, 2021	BUY	$1.97 - $2.89 $10,645 - $15,617	5,404 Added 101.26%	10,741 $30,000
Q4 2020 Feb 16, 2021	SELL	$1.49 - $3.1 $6,058 - $12,604	-4,066 Reduced 43.24%	5,337 $10,000
Q3 2020 Nov 16, 2020	SELL	$1.7 - $2.98 $1,594 - $2,795	-938 Reduced 9.07%	9,403 $17,000
Q2 2020 Aug 13, 2020	BUY	$1.74 - $3.19 $17,993 - $32,987	10,341 New	10,341 $23,000
Q3 2018 Nov 13, 2018	SELL	$0.7 - $1.58 $576 - $1,301	-824 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$0.71 - $4.04 $3,545 - $20,171	-4,993 Reduced 85.83%	824 $1,000
Q1 2018 May 15, 2018	BUY	$3.91 - $7.83 $17,684 - $35,415	4,523 Added 349.54%	5,817 $24,000
Q4 2017 Feb 09, 2018	BUY	$3.9 - $7.77 $5,046 - $10,054	1,294	1,294 $8,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.33B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.